Improvements in imaging and genetic testing technologies such as next generation sequencing have allowed for most birth defects to be identified prenatally. There is a lack of available literature describing the current outcomes of fetuses where prenatal structural anomalies have been detected.
RESULTS:
Of the 112 cases identified, 92.9% of the congenital anomalies were first identified by ultrasound, 28.6% underwent genetic testing, and 14.3% resulted in elective termination of the fetus. Congenital abnormalities were stratified by severity, in accordance with a scale reported by Thomas et al, Birth Defects Research Part A, 2016 . These results showed that fetal morbidity is associated with greater rate of elective termination. A subgroup analysis was done to evaluate patient characteristics between pregnancies that were continued compared with those that were terminated. Termination was associated with shorter gestation at the time of FCC (p=.002) and prior therapeutic terminations (p=.016) by Student's t-test. Rates of genetic testing were collinear with severity of prenatal condition. Pearson chi-square test suggests genetic testing did not predispose termination, although there is a trend towards significance (p=0.077). Cleft lip and palate were observed in 6.25% of cases. Within this group, there were no terminations, 71.4% underwent prenatal MRI, and 57% had genetic testing.
CONCLUSION:
This study describes the current practices of a prenatal consultation service at an academic tertiary care hospital. In concordance with previous studies, more severe anomalies are more likely to be terminated. Almost all antenatal diagnoses of congenital malformations were identified by first trimester ultrasonography screen. The decision to pursue genetic testing is correlated with anomaly morbidity but greater sample size is necessary to determine the role of genetic testing in the decision to terminate. In the case of clefts where there can be a clear genetic cause, 57.0% compared to the overall rate of 28.6% opted for genetic testing. Continued monitoring of the role of genetic testing in prenatal diagnosis of congenital anomalies is needed in the era of personalized medicine. PURPOSE: Previous attempts to study the effect of prophylactic antibiotics on the outcomes of cleft palate surgery have been hampered by the need for a very large sample size to provide adequate power to discern a potentially small therapeutic effect. This limitation can be overcome by querying large databases created by healthcare governing bodies or healthcare alliances.
METHODS:
We queried the Pediatric Health Information System (PHIS) database for de-identified billing records. This meta-dataset was accumulated from 47 participating children's hospitals. We identified patients within the PHIS database who had undergone primary palatoplasty, ICD-9 code 749.21, between 2007 and 2012. Patients between 6-18 months old at the time of surgery were included. We determined how many of these patients had undergone repair of an oronasal fistula, ICD-9 procedure code 21.82, between 2007 and 2015. Pharmacy billing records for each patient were queried for charges for antibiotic administration. Our primary analysis consisted of two groups. Group 1 received no preoperative antibiotics. Group 2 received a dose of preoperative antibiotics. Our secondary analysis also consisted of 2 groups. Group 1 received no antibiotics.
